Das Zentrum
Multiple Sklerose Zentrum Dresden
Patienteninformation
Kontaktinformation
Behandlungsteam
Studienteam
Neuropsychologie
Mobilitätszentrum
Das Mobilitätszentrum
Ganganalyse
Sprunganalyse
DIERS
EMIQ
Forschungsprojekte
Neuroimmunologisches Labor
Das NIL
Neurofilament-Leichtketten Analyse
Autonomes & Neuroendokrinologisches Funktionslabor
Das ANF
Untersuchungsmethoden
MS Living Lab
Management & Science
Team Management & Science
Projekte
eHealth & Analytics
MSDS 3D
MSDS Klinik & Praxis
MS-HRS
MTRS
MS Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2025
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digitalkalender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
Deutsch
Deutsch
English
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS
MS Treatments
Jahr
Publikationsjahr
2020
Autoren
Autorenliste der Publikation
Moser T, Schwenker K, Seiberl M, Feige J, Akgün K, Haschke-Becher E, Ziemssen T, Sellner J.
Verlag
Publisher-Information
Ann Clin Transl Neurol. 2020 Nov;7(11):2199-2212.
Link
Zur Publikation (externer Server)
https://doi.org/10.1002/acn3.51206
Tags
Forschungsthemen
Multiple Sklerose
MS Behandlung
Treatments
2020
Patient profiling in relapsing multiple sclerosis: insights from a real-world observational study into the unmet medical needs of patients on disease-modifying therapy
Multiple Sclerosis
Jahr
2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews
Multiple Sclerosis
Jahr
2026
Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis
NIL
Jahr
2025
A Review of the Impact of Platform Therapies (DMTs) on Associated Clinical Symptoms of Multiple Sclerosis
MS Treatments
Jahr
2025
Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosis
Multiple Sclerosis
Jahr
2025
